Last Price | 11.70 | Max Price | 13.30 |
Min Price | 10.80 | 1 Year return | 0.86 |
Avg. Target | 20.80 | Expected Return | 77.78 % |
Sector | Health Care | Subsector | Biotechnology |
Sell | 0 | Rating | |
Hold | 0 | Concensus | |
Buy | 2 |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 141,925 | 0.00 % |
2020 | 0 | 170,231 | 0.00 % |
2021 | 3 | 252,886 | 0.00 % |
2022 | 3 | 238,500 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
April 05, 2024 | DeGroof Petercam | Hyloris | Buy | 22.10 | 47.06 % |
October 19, 2023 | KBC Securities | Hyloris | Buy | 19.50 | 40.00 % |
May 02, 2023 | KBC Securities | Hyloris | Buy | 19.50 | 38.72 % |
November 28, 2022 | Berenberg | Hyloris | Buy | 20.00 | 37.00 % |
July 17, 2022 | KBC Securities | Hyloris | Buy | 19.50 | 43.33 % |
February 25, 2022 | KBC Securities | Hyloris | Buy | 19.50 | 30.26 % |
December 17, 2021 | KBC Securities | Hyloris | Buy | 17.50 | 26.17 % |
October 13, 2021 | KBC Securities | Hyloris | Buy | 16.50 | 25.21 % |
October 08, 2021 | KBC Securities | Hyloris | Buy | 15.50 | 17.03 % |
August 04, 2021 | KBC Securities | Hyloris | Buy | 15.00 | 2.93 % |
May 18, 2021 | Berenberg | Hyloris | Buy | 18.00 | 13.00 % |
March 09, 2021 | KBC Securities | Hyloris | Buy | 15.00 | 4.00 % |
February 05, 2021 | KBC Securities | Hyloris | Buy | 13.00 | -30.77 % |
January 07, 2021 | Berenberg | Hyloris | Buy | 15.00 | -22.00 % |
September 10, 2020 | KBC Securities | Hyloris | Buy | 12.00 | -10.83 % |
August 07, 2020 | KBC Securities | Hyloris | Buy |
No Records Found
No Records Found
No Records Found
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
|
Costs |
0
|
0
|
4
|
6
|
6
|
7
|
Profit |
0
|
0
|
-4
|
-6
|
-6
|
-7
|
Margin of profit |
0.0
|
0.0
|
-1771.43
|
-6711.11
|
-6411.11
|
-3972.22
|
ROI |
0.0
|
0.0
|
86.71
|
268.44
|
56.62
|
-12.11
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
0
|
-4
|
-2
|
-10
|
59
|
Debt |
0
|
0
|
9
|
10
|
16
|
10
|
Total assets |
0
|
0
|
4
|
8
|
6
|
69
|
Solvency |
0.0
|
0.0
|
-98.17
|
-28.30
|
-170.40
|
85.37
|
Cash |
0
|
0
|
0
|
3
|
0
|
64
|
Cashflow |
0
|
0
|
-2
|
-5
|
-5
|
-5
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
0.0
|
-0.19
|
-0.53
|
-0.28
|
-0.45
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
0.0
|
11.70
|
Eps |
0.0
|
-1.27
|
-1.79
|
-1.60
|
-0.33
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
-35.45
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.0
|
-0.24
|
-0.13
|
-0.57
|
2.31
|
Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
0.20
|
Cashflow per stock |
0.0
|
-0.09
|
-0.30
|
-0.26
|
-0.18
|
Stocks |
0
|
18
|
18
|
18
|
26
|
Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
299.43
|
Date
|
Price
|
---|---|
10 May 2024
|
11.70
|
07 May 2024
|
11.70
|
01 May 2024
|
11.70
|
22 Apr 2024
|
11.95
|
18 Apr 2024
|
11.95
|
17 Apr 2024
|
12.00
|
09 Apr 2024
|
12.55
|
05 Apr 2024
|
11.65
|
03 Apr 2024
|
11.80
|
30 Mar 2024
|
11.45
|
22 Mar 2024
|
11.10
|
18 Mar 2024
|
11.95
|
15 Mar 2024
|
12.30
|
12 Mar 2024
|
12.85
|
11 Mar 2024
|
12.95
|
09 Mar 2024
|
12.95
|
07 Mar 2024
|
12.20
|
01 Mar 2024
|
12.25
|
29 Feb 2024
|
12.30
|
27 Feb 2024
|
11.75
|
22 Feb 2024
|
12.30
|
21 Feb 2024
|
12.45
|
20 Feb 2024
|
12.80
|
15 Feb 2024
|
12.90
|
14 Feb 2024
|
12.90
|
13 Feb 2024
|
13.10
|
09 Feb 2024
|
13.20
|
08 Feb 2024
|
13.20
|
07 Feb 2024
|
12.80
|
06 Feb 2024
|
13.00
|